Executive Summary: State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.

Dr. Advani is an Adjunct Associate Professor of Medicine at Duke University School of Medicine. In July 2024, she joined GSK/ViiV Healthcare as a scientific leadership physician with cross functional experience across global medical affairs as well as Research & Development in HIV therapeutics and vaccines.

Prior to this, she served as a physician investigator in the Duke Center for Antimicrobial Stewardship and Infection Prevention, a Fellow in Implementation Science at HIGH IRI (HIV, Infectious Disease and Global Health Implementation Research) Institute at Washington University, St Louis and Associate Medical Director of Infection Prevention at Yale New Haven Hospital. Her research focused on improving the diagnosis of UTIs in older adults, implementation of diagnostic stewardship interventions, and de-prescribing antibiotics for asymptomatic bacteriuria. She was awarded the K12 Urologic Career Development Award, Pepper Center Career Development Award, and SHEA Research Scholar Award to continue her UTI related research. In addition, she was one of the key investigators for CDC Prevention Epicenter Program and CDC SHEPheRD Contract for the Use of Race, Ethnicity, and Social Determinants of Health Data in NHSN Measures to Promote Health Equity.

Dr. Siddiqui is a clinician-scientist in the field of Urogynecology & Reconstructive Pelvic Surgery. She leads the Duke Urogenital Microbiome (Ur-BIOME) Research Program and has particular interest in how microbial factors influence recurrent UTIs and overactive bladder. She also serves as the Duke site PI for the Pelvic Floor Disorders Network, which is an NIH-sponsored group of investigators conducting clinical trials to improve the lives of women with pelvic floor issues.